NeuroImages. Cerebral shotgun pellet embolism.

347:146–151. 37. Pierot L, Desnos C, Blin J, et al. D1 and D2-type dopamine receptors in patients with Parkinson’s disease and progressive supranuclear palsy. J Neurol Sci 1988;86:291–306. 38. Rinne JO, Laihinen A, Lönnberg P, Marjamäki P, Rinne UK. A postmortem study on striatal dopamine receptors in Parkinson’s disease. Brain Res 1991;556:117–122. 39. Gurevich EV, Joyce JN. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 1999;20:60–80. 40. Dooley M, Markham A. Pramipexole. A review of its use in the management of early and advanced Parkinson’s disease. Drugs Aging 1998;12:495–514. 41. Antonini A, Schwarz J, Oertel WH, Beer HF, Madeja UD, Leenders KL. [C]Raclopride and positron emission tomography in previously untreated patients with Parkinson’s disease: influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology 1994;44:1325–1329. 42. Herrero MT, Augood SJ, Asensi H, et al. Effects of L-DOPA therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys. Brain Res Mol Brain Res 1996;42:149–155. 43. Morissette M, Goulet M, Calon F, et al. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. Mol Pharmacol 1996;50:1073–1079. 44. Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz JC. Induction of D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci 1997; 94:3363–3367. 45. Tamaru F. Disturbances in higher function in Parkinson’s disease. Eur Neurol 1997;38(suppl 2):33–36. 46. Weinberger DR, Berman KF, Chase TN. Mesocortical dopaminergic function and human cognition. Ann NY Acad Sci 1988; 537:330–338. 47. Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RS, Dolan RJ. Depression in Parkinson’s disease. A positron emission study. Br J Psychiatry 1994;165:333–339. 48. Grossman M, Crino P, Reivich M, Stern MB, Hurtig HI. Attention and sentence processing deficits in Parkinson’s disease: the role of anterior cingulate cortex. Cereb Cortex 1992; 2:513–525. 49. Ribeyre JM, Lesieur P, Varoquaux O, Dollfus S, Pays M, Petit M. A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia. Biol Psychiatry 1994;36:230–236. 50. Farde L, Gustavsson JP, Jönsson E. D2 dopamine receptors and personality traits. Nature 1997;385:590. 51. Alexander GE, Delong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357–381. 52. Joyce JN, Goldsmith SG, Gurevich EV. Limbic circuits and monoamine receptors: dissecting the effects of antipsychotics from disease processes. J Psychiatr Res 1997;31:197–217.